To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
AlveoliX AGIn-vitro models inspired by nature
We aim at changing the way drug development research is done today by providing in-vitro models that reproduce the in-vivo environment in an unprecedented way. These in-vitro models, called organ-on-chips, will make it possible to better predict drugs’ responses in humans than standard in-vitro and in-vivo models and as a consequence to importantly reduce animal testing.
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
- 1Intas Biopharmaceuticals Ltd.
- 2LPT - Laboratory of Pharmacology and Toxicology GmbH & Co. KG
- 3Ranbaxy Laboratories Ltd.
- 4Life Technologies Corporation
- 5Scientis Pharma SA
- 6MEDICE Arzneimittel Pütter GmbH & Co. KG
- 7Sanofi-Aventis Deutschland GmbH
- 8TranScrip Partners
- 9BIOTON S.A.
- 10Abbott GmbH & Co. KG